Results from the ReOpen1 and ReOpen2 trials, both spanning 24 weeks, revealed that XHANCE significantly improved symptoms, sinus opacification, and quality of life for CRS patients, regardless of ...

Among patients reporting any perceived degree of disease improvement despite treatment, mean changes in in CT scans of sinuses as scored by sinus opacification were at least –2.86, or at least ...

The EDS-FLU improved symptoms and sinus opacification in patients with chronic rhinosinusitis without nasal polyps.

And for sinus percent opacification, as assessed by week-24 CT scans, patients had a LS mean change of -6.07 with fluticasone versus 1.19 with placebo (P<0.001).

For an adult with chronic rhinosinusitis, the surgeon should not endorse or require a predefined regimen or duration of medical therapy as a prerequisite to sinus surgery. HealthDay News — In a ...

Not surprisingly, the Lund-Mackay score was approximately 38% lower in the CRSsNP group, at 7.4 (2.3) vs 11.9 (3.6) (P = .016); the lower the Lund-Mackay score, the lesser the sinus opacification.